K2 PRINCIPAL FUND L.P. 13D and 13G filings for Pasithea Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-31 6:21 pm Sale | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 54,721 4.990% | -30,279 (-35.62%) | Filing |
| 2021-12-20 4:00 pm Purchase | 2021-11-29 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 85,000 7.480% | 85,000 (New Position) | Filing |